Although there are some similarities between the way that US and European authorities uphold antibody patents, there are also some important differences.
Monika Rai
Advertisement
Monika Rai is a partner at Mathys & Squire LLP. Her practice focuses on proceedings at the European Patent Office in the field of diagnostics, biopharmaceuticals and biologics and advising on IP due diligence projects.
Articles by Monika Rai
Advertisement
Latest Updated Articles
Patenting Antibodies in EuropePublished: September 1st 2018 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
5
